Presentation is loading. Please wait.

Presentation is loading. Please wait.

Assessment and Pharmacological Treatment of Tobacco Dependence

Published byArline West Modified over 9 years ago

Similar presentations

Presentation on theme: "Assessment and Pharmacological Treatment of Tobacco Dependence"— Presentation transcript:

1 Assessment and Pharmacological Treatment of Tobacco Dependence
Jill Williams, M.D. Associate Professor of Psychiatry UMDNJ-Robert Wood Johnson Medical School, UMDNJ-School of Public Health Copyright Alcohol Medical Scholars Program

2 Smoking = Big Health Problem
#1 preventable cause morbidity/ mortality 1 in 5 deaths in US But….Treatment Improves Outcomes ~50% of smokers try to quit/ year Advice from MD ↑ quitting Double success with treatment Copyright Alcohol Medical Scholars Program

3 This Lecture will Cover
Epidemiology /consequences Nicotine pharmacology Assessment Pharmacological treatments Copyright Alcohol Medical Scholars Program

4 Epidemiology of Tobacco Use
Cigarettes > 95% of all tobacco use >1 billion tobacco users worldwide Stable or ↓ in US/ developed nations Increasing in developing countries Higher rates in ↓ SES Copyright Alcohol Medical Scholars Program

5 Smoking Prevalence Rates
Copyright Alcohol Medical Scholars Program

6 Copyright Alcohol Medical Scholars Program
Women and Smoking Rates men ~ women Highest in those living below the poverty level Lung cancer # 1 cancer death Cancer Death Rates in Women after 1950 MMWR 1993 Copyright Alcohol Medical Scholars Program

7 Smoking A Pediatric Epidemic
>5 million children will die prematurely from cigarettes Most adults started < age 18 During grades 6-9 If start age 1.6x more dependence Copyright Alcohol Medical Scholars Program

8 Tobacco-Caused Illness
~90% of all lung cancers ~100% COPD 2X death from stroke/ CAD Half of all smokers die from a tobacco-caused disease Surgeon General’s Report 2004 Copyright Alcohol Medical Scholars Program

9 Copyright Alcohol Medical Scholars Program
Other Consequences Other Cancers Oral Esophagus (cigars/ chew) Cervix Bladder Pancreas (cigars) Costs > $100 billion annually Primary cause of fatal house fires Copyright Alcohol Medical Scholars Program

10 It’s the Smoke that Kills
Cigarette smoke > 4000 compounds Acetone, Cyanide, Carbon Monoxide, Formaldehyde > 60 Carcinogens Benzene, Nitrosamines (CDC 2003) Copyright Alcohol Medical Scholars Program

11 Environmental Tobacco Smoke
ETS is a known human carcinogen (Class1A), in the same class as asbestos 50,000 additional deaths/ year in non-smokers ~3000 from lung cancer Copyright Alcohol Medical Scholars Program

12 This Lecture will Cover
Epidemiology /consequences Nicotine pharmacology Assessment Pharmacological treatments Copyright Alcohol Medical Scholars Program

13 Nicotine Pharmacology
Pharmacology depends on delivery route Reaches brain in 10 sec Arterial levels 6-10x higher than venous Half-life 2 hours Metabolized to cotinine in liver Copyright Alcohol Medical Scholars Program

14 Copyright Alcohol Medical Scholars Program
Russell et al., BMJ, 1983 Copyright Alcohol Medical Scholars Program

15 Copyright Alcohol Medical Scholars Program
Nicotine Possible therapeutic effects: Alzheimer's Attention deficit disorder Autism Schizophrenia Ulcerative colitis Copyright Alcohol Medical Scholars Program

16 Copyright Alcohol Medical Scholars Program
Nicotine Safety Smokers misinformed about safety/efficacy of nicotine Not a carcinogen Not a significant risk factor for cardiovascular events Risk-benefit ratio supports nicotine medications over using tobacco Copyright Alcohol Medical Scholars Program

17 This Lecture will Cover
Epidemiology /consequences Nicotine pharmacology Assessment Pharmacological treatments Copyright Alcohol Medical Scholars Program

18 Copyright Alcohol Medical Scholars Program
Nicotine Dependence ≥ 90% smokers meet dependence criteria withdrawal tolerance desire or efforts to cut down/ control use great time spent in obtaining/using reduced occupational, recreational activities use despite problems larger amounts consumed than intended Copyright Alcohol Medical Scholars Program

19 Copyright Alcohol Medical Scholars Program
Nicotine Withdrawal Depressed mood Insomnia Irritability, frustration or anger Anxiety Difficulty concentrating Restlessness Decreased heart rate Increased appetite or weight gain Copyright Alcohol Medical Scholars Program

20 Heaviness of Smoking Index= Measure of Dependence
Number of cigarettes per day (cpd) AM Time to first cigarette (TTFC) ≤ 30 minutes = moderate ≤ 5 minutes = severe (Heatherton 1989) Copyright Alcohol Medical Scholars Program

21 Hard to Quit Without Treatment
70% of smokers want to quit Few quit without treatment < 1/3 remain abstinent for 2 days < 5% ultimately successful per quit attempt Copyright Alcohol Medical Scholars Program

22 Copyright Alcohol Medical Scholars Program
Role of Physician 5As Ask, Advise, Assess, Assist, Arrange Brief physician advice ↑ quitting 10% quit rates with < 3 minutes 20% quit rates >10 minutes Tobacco dependence = chronic condition < 25% successful on first attempt > 8 quit attempts before successful Copyright Alcohol Medical Scholars Program

23 This Lecture will Cover
Epidemiology /consequences Nicotine pharmacology Assessment Pharmacological treatments Copyright Alcohol Medical Scholars Program

24 Pharmacological Treatment
Rationale Reduce or eliminate withdrawal Block reinforcing effects of nicotine Manage negative mood states Unlearn smoking behaviors Cost-effective treatment Copyright Alcohol Medical Scholars Program

25 Pharmacological Treatment
Nicotine Replacement Patch Gum Lozenge Inhaler Nasal Spray Bupropion Varenicline Copyright Alcohol Medical Scholars Program

26 Nicotine Replacement Therapy (NRT)
Nicotine absorption poorer than cigs Lower dose delivered Poorly orally absorbed; ↑ first pass metabolism Less rewarding than smoking Under dosing common Worsened by poor compliance Copyright Alcohol Medical Scholars Program

27 Few Contraindications to NRT
With caution if: Recent MI Smokes < 10 cpd Pregnant/breastfeeding Adolescents (Not FDA approved) Mild side effects Mostly local Systemic, less common Copyright Alcohol Medical Scholars Program

28 Copyright Alcohol Medical Scholars Program
Nicotine Patch Slow onset Continuous delivery 24 or 16 hour dosing Easy, good compliance Gradual taper Side effects- skin, insomnia OTC Copyright Alcohol Medical Scholars Program

29 Copyright Alcohol Medical Scholars Program
Nicotine Gum Use every 1 hour Bite and “park” Slow, buccal absorption Acidic foods ↓ absorption Slight mouth, throat burning Dose: 2mg < 25 cpd 4mg > 25 cpd OTC Copyright Alcohol Medical Scholars Program

30 Copyright Alcohol Medical Scholars Program
Nicotine Lozenge Don’t chew 2 and 4mg dose Up to 20 lozenges/ daily Dose based on TTFC 2mg if > 30 mins 4 mg< 30 mins OTC; No generics Copyright Alcohol Medical Scholars Program

31 Copyright Alcohol Medical Scholars Program
Nicotine Inhaler 6-16 cartridges/day Puff for minutes Misnomer (Oral puffer) Acidic foods ↓ absorption Slight throat irritation, cough Rx needed Copyright Alcohol Medical Scholars Program

32 Copyright Alcohol Medical Scholars Program
Nicotine Nasal Spray Rapid delivery Most side effects (nasal irritation, rhinitis, coughing, watering eyes) 2 sprays= 1 dose Up to 40 doses/day Some dependence liability Rx needed Copyright Alcohol Medical Scholars Program

33 Copyright Alcohol Medical Scholars Program
Bupropion SR Nonsedating/ activating Affects NE and DA, nicotine receptor Side effects- headache, insomnia Don’t use: seizures/ eating disorder Start days prior to quit date 300mg dose has least weight gain Rx needed Copyright Alcohol Medical Scholars Program

34 Efficacy of Medications
NRT 2x success vs. placebo 25-30% Efficacy Efficacy NRT ≃ bupropion Patient preference, cost, tolerability Combinations Improve Outcomes Copyright Alcohol Medical Scholars Program

35 Copyright Alcohol Medical Scholars Program
Varenicline Nicotinic partial agonist 1mg BID dose superior to placebo or bupropion in 12 week trials Additional 12 weeks prevented relapse Nausea, headache, insomnia and abnormal dreams- most common side effects Discontinuation rate similar to placebo Gonzales et al., 2006; Tonstad et al., 2006; Jorenby et al., 2006 Copyright Alcohol Medical Scholars Program

36 Copyright Alcohol Medical Scholars Program
Conclusions It’s the smoke that kills – not the nicotine All practitioners should treat tobacco Treatments ↑success Six FDA approved treatments: effective and well tolerated Copyright Alcohol Medical Scholars Program

37 Copyright Alcohol Medical Scholars Program
Free Resources 1. PHS Guidelines 2. Surgeon General Report (2004) smokingconsequences/ Copyright Alcohol Medical Scholars Program

Download ppt "Assessment and Pharmacological Treatment of Tobacco Dependence"

Similar presentations

Chapter 13. What is a risk of tobacco use? Recognize various forms of tobacco Identify some of the harmful substances Describe the negative effects tobacco.

Chapter 13. What is a risk of tobacco use? Recognize various forms of tobacco Identify some of the harmful substances Describe the negative effects tobacco.
Nicotine Addiction Pharmacy Practice II Winter 2005.

Nicotine Addiction Pharmacy Practice II Winter 2005.
STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.

STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.
Tobacco & Cancer. Tobacco Use And Cancer Tobacco use, the most preventable cause of death in our society, accounts for at least 30% of all cancer deaths.

Tobacco & Cancer. Tobacco Use And Cancer Tobacco use, the most preventable cause of death in our society, accounts for at least 30% of all cancer deaths.
In the name of GOD Decreasing smoking behavior and risk through CYP2A6 inhibition Shadi Sarahroodi (Pharm.D) Ahvaz Jondishapour University of medical.

In the name of GOD Decreasing smoking behavior and risk through CYP2A6 inhibition Shadi Sarahroodi (Pharm.D) Ahvaz Jondishapour University of medical.
Chapter 20: The Effects of Tobacco Use. Key Terms  Nicotine  Stimulant  Carcinogen  Tar  Carbon Monoxide  Smokeless Tobacco  Leukoplakia  Nicotine.

Chapter 20: The Effects of Tobacco Use. Key Terms  Nicotine  Stimulant  Carcinogen  Tar  Carbon Monoxide  Smokeless Tobacco  Leukoplakia  Nicotine.
IS WACKO Tobacco. Tobacco: A tall, leafy annual plant originally grown in South and Central America. Nicotine: A stimulant that is naturally found in.

IS WACKO Tobacco. Tobacco: A tall, leafy annual plant originally grown in South and Central America. Nicotine: A stimulant that is naturally found in.
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine

ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
Smoking and mental health Mark Allen Specialist Health Improvement Practitioner.

Smoking and mental health Mark Allen Specialist Health Improvement Practitioner.
Treatment of Tobacco Dependence in 2012 J. Taylor Hays, MD Professor of Medicine Associate Director Nicotine Dependence Center Mayo Clinic Rochester, MN.

Treatment of Tobacco Dependence in 2012 J. Taylor Hays, MD Professor of Medicine Associate Director Nicotine Dependence Center Mayo Clinic Rochester, MN.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.

Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Key Public Health issues of smoking Passive smoking in home, car, workplace, restaurants etc. Self- induced disease and cost of smoking related diseases.

Key Public Health issues of smoking Passive smoking in home, car, workplace, restaurants etc. Self- induced disease and cost of smoking related diseases.
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.

Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.
Pharmacotherapy for the Treatment of Nicotine Dependence Donna Shelley, MD, MPH, Columbia University Mailman School of Public Health

Pharmacotherapy for the Treatment of Nicotine Dependence Donna Shelley, MD, MPH, Columbia University Mailman School of Public Health
QUIT NOW. BARRIERS TO QUITTING Nicotine is a potent psychoactive drug that causes physical dependence and tolerance. In the absence of nicotine, a smoker.

QUIT NOW. BARRIERS TO QUITTING Nicotine is a potent psychoactive drug that causes physical dependence and tolerance. In the absence of nicotine, a smoker.
James M. Eddy Texas A&M University The Health Effects of Smoking.

James M. Eddy Texas A&M University The Health Effects of Smoking.
Introduction to Smoking Cessation MSSM III Edward Anselm, M.D. Assistant Professor of Medicine Icahn School of Medicine at Mount Sinai Medical Director,

Introduction to Smoking Cessation MSSM III Edward Anselm, M.D. Assistant Professor of Medicine Icahn School of Medicine at Mount Sinai Medical Director,
SMOKING CESSATION Leading Preventable Cause of Death 400,000 to 500,000 deaths per year in USA 3 Million deaths world wide 1 of every 6 deaths in USA Directly.

SMOKING CESSATION Leading Preventable Cause of Death 400,000 to 500,000 deaths per year in USA 3 Million deaths world wide 1 of every 6 deaths in USA Directly.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Treating Tobacco Use.

Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Treating Tobacco Use.

Similar presentations

Ads by Google